Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Derfuss

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Revue Medicale Suisse|March 5, 2013
[What's new in multiple sclerosis therapy?]C Vaney, T Derfuss
Current Topics in Microbiology and Immunology|September 13, 2002
Herpesviral proteins regulating apoptosisT Derfuss, E Meinl
Der Nervenarzt|July 9, 2016
[Cell depletion and myoablation for neuroimmunological diseases]M Diebold, L Kappos, T Derfuss
Der Nervenarzt|November 2, 2001
[Multiple sclerosis. Chlamydia hypothesis in debate]T Derfuss, R Hohlfeld, E Meinl
Current Medical Research and Opinion|June 30, 2015
Efficacy of fingolimod in patients with highly active relapsing-remitting multiple sclerosisT Derfuss, N K Bergvall, N Sfikas, et al.
Journal of Neurology|January 30, 2019
Magnetic resonance imaging in immune-mediated myelopathiesM J Wendebourg, S Nagy, T Derfuss, et al.
Brain Pathology (Zurich, Switzerland)|September 15, 2001
Prevalence of HSV-1 LAT in human trigeminal, geniculate, and vestibular ganglia and its implication for cranial nerve syndromesD Theil, V Arbusow, T Derfuss, et al.
Journal of Virology|June 17, 1998
Antiapoptotic activity of the herpesvirus saimiri-encoded Bcl-2 homolog: stabilization of mitochondria and inhibition of caspase-3-like activityT Derfuss, H Fickenscher, M S Kraft, et al.
European Journal of Clinical Investigation|August 17, 2005
Immunoadsorption patients with multiple sclerosis: an open-label pilot studyA Moldenhauer, J Haas, C Wäscher, et al.
Acta Neurologica Scandinavica|June 15, 2013
Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosisJ Kuhle, C Malmeström, M Axelsson, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Revue Medicale Suisse|March 5, 2013
[What's new in multiple sclerosis therapy?]C Vaney, T Derfuss
Current Topics in Microbiology and Immunology|September 13, 2002
Herpesviral proteins regulating apoptosisT Derfuss, E Meinl
Der Nervenarzt|July 9, 2016
[Cell depletion and myoablation for neuroimmunological diseases]M Diebold, L Kappos, T Derfuss
Der Nervenarzt|November 2, 2001
[Multiple sclerosis. Chlamydia hypothesis in debate]T Derfuss, R Hohlfeld, E Meinl
Current Medical Research and Opinion|June 30, 2015
Efficacy of fingolimod in patients with highly active relapsing-remitting multiple sclerosisT Derfuss, N K Bergvall, N Sfikas, et al.
Journal of Neurology|January 30, 2019
Magnetic resonance imaging in immune-mediated myelopathiesM J Wendebourg, S Nagy, T Derfuss, et al.
Brain Pathology (Zurich, Switzerland)|September 15, 2001
Prevalence of HSV-1 LAT in human trigeminal, geniculate, and vestibular ganglia and its implication for cranial nerve syndromesD Theil, V Arbusow, T Derfuss, et al.
Journal of Virology|June 17, 1998
Antiapoptotic activity of the herpesvirus saimiri-encoded Bcl-2 homolog: stabilization of mitochondria and inhibition of caspase-3-like activityT Derfuss, H Fickenscher, M S Kraft, et al.
European Journal of Clinical Investigation|August 17, 2005
Immunoadsorption patients with multiple sclerosis: an open-label pilot studyA Moldenhauer, J Haas, C Wäscher, et al.
Acta Neurologica Scandinavica|June 15, 2013
Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosisJ Kuhle, C Malmeström, M Axelsson, et al.
Pageof 3